American International Group, Inc. Coherus Bio Sciences, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.02 - $3.14 $4,288 - $6,666
2,123 Added 4.28%
51,732 $123,000
Q4 2023

Feb 13, 2024
SELL
$1.59 - $3.85 $318 - $770
-200 Reduced 0.4%
49,609 $165,000
Q3 2023

Nov 13, 2023
BUY
$3.74 - $5.45 $33,858 - $49,338
9,053 Added 22.21%
49,809 $186,000
Q2 2023

Aug 04, 2023
BUY
$3.79 - $8.3 $4,256 - $9,320
1,123 Added 2.83%
40,756 $174,000
Q1 2023

May 12, 2023
BUY
$5.89 - $10.52 $1,431 - $2,556
243 Added 0.62%
39,633 $271,000
Q4 2022

Feb 10, 2023
SELL
$5.69 - $10.07 $1,633 - $2,890
-287 Reduced 0.72%
39,390 $311,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $13.87 $3,334 - $6,449
465 Added 1.19%
39,677 $381,000
Q2 2022

Aug 12, 2022
BUY
$5.86 - $13.23 $12,112 - $27,346
2,067 Added 5.56%
39,212 $284,000
Q1 2022

May 13, 2022
SELL
$10.92 - $16.41 $24,963 - $37,513
-2,286 Reduced 5.8%
37,145 $480,000
Q4 2021

Feb 11, 2022
SELL
$15.81 - $18.99 $12,126 - $14,565
-767 Reduced 1.91%
39,431 $629,000
Q3 2021

Nov 12, 2021
SELL
$12.68 - $17.79 $21,213 - $29,762
-1,673 Reduced 4.0%
40,198 $646,000
Q2 2021

Aug 13, 2021
SELL
$12.95 - $15.41 $337,023 - $401,045
-26,025 Reduced 38.33%
41,871 $579,000
Q1 2021

May 07, 2021
SELL
$14.42 - $21.39 $60,333 - $89,495
-4,184 Reduced 5.8%
67,896 $992,000
Q4 2020

Feb 12, 2021
BUY
$16.56 - $18.94 $524,140 - $599,469
31,651 Added 78.29%
72,080 $1.25 Million
Q3 2020

Nov 04, 2020
SELL
$17.41 - $19.89 $14,241 - $16,270
-818 Reduced 1.98%
40,429 $742,000
Q2 2020

Aug 12, 2020
BUY
$14.43 - $19.16 $60,663 - $80,548
4,204 Added 11.35%
41,247 $737,000
Q1 2020

May 04, 2020
SELL
$11.67 - $22.53 $24,985 - $48,236
-2,141 Reduced 5.46%
37,043 $601,000
Q4 2019

Feb 05, 2020
BUY
$16.33 - $21.37 $1,632 - $2,137
100 Added 0.26%
39,184 $706,000
Q3 2019

Nov 08, 2019
SELL
$16.3 - $23.37 $4,449 - $6,380
-273 Reduced 0.69%
39,084 $792,000
Q2 2019

Aug 13, 2019
BUY
$13.1 - $22.1 $81,927 - $138,213
6,254 Added 18.89%
39,357 $870,000
Q1 2019

May 06, 2019
SELL
$8.38 - $15.5 $8,983 - $16,616
-1,072 Reduced 3.14%
33,103 $452,000
Q4 2018

Feb 13, 2019
SELL
$8.65 - $16.28 $2,274 - $4,281
-263 Reduced 0.76%
34,175 $309,000
Q3 2018

Nov 09, 2018
BUY
$14.45 - $20.25 $56,947 - $79,805
3,941 Added 12.92%
34,438 $568,000
Q2 2018

Aug 08, 2018
BUY
$10.25 - $17.45 $53,054 - $90,321
5,176 Added 20.44%
30,497 $427,000
Q1 2018

May 07, 2018
SELL
$9.1 - $13.7 $4,704 - $7,082
-517 Reduced 2.0%
25,321 $280,000
Q4 2017

Feb 09, 2018
BUY
$8.35 - $14.4 $1,027 - $1,771
123 Added 0.48%
25,838 $227,000
Q3 2017

Nov 09, 2017
BUY
$11.1 - $14.5 $285,436 - $372,867
25,715
25,715 $343,000

Others Institutions Holding CHRS

# of Institutions
135
Shares Held
77.9M
Call Options Held
40.7K
Put Options Held
50.1K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $115M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email